CYP2D6

CYP2D6, also known as cytochrome P450 2D6, is an important enzyme involved in the metabolism of many drugs, including antidepressants, antipsychotics, opioids, and beta-blockers. This enzyme is primarily expressed in the liver, but it can also be found in other tissues throughout the body. The activity of CYP2D6 varies greatly among individuals due to genetic polymorphisms that affect enzyme expression and function. Some individuals may have increased activity of CYP2D6, while others may have decreased activity or even a complete lack of the enzyme. This can have significant implications for drug metabolism and can impact clinical outcomes. CYP2D6 has received particular attention in the field of precision medicine, as genetic testing for CYP2D6 polymorphisms can be used to inform drug dosing and selection. For example, individuals with reduced CYP2D6 activity may require lower doses of drugs that are primarily metabolized by this enzyme to avoid adverse reactions. In recent years, the study of CYP2D6 has gained even greater relevance in the context of COVID-19, as some studies have suggested that certain CYP2D6 polymorphisms may play a role in disease severity and outcome. This highlights the importance of ongoing research and understanding of this key enzyme in the context of both drug metabolism and disease susceptibility.